All Stories

  1. Population Pharmacokinetics of Artemether, Dihydroartemisinin, and Lumefantrine in Rwandese Pregnant Women Treated for UncomplicatedPlasmodium falciparumMalaria

    Article • Antimicrobial Agents and Chemotherapy, July 2018, ASM Journals

    Ms Jesmin JPD Lohy Das, Dr Thomas Petrus Catharina Dorlo

  2. Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis

    Article • Antimicrobial Agents and Chemotherapy, December 2016, ASM Journals

    Dr Thomas Petrus Catharina Dorlo

  3. Validation and Clinical Evaluation of a Novel Method To Measure Miltefosine in Leishmaniasis Patients Using Dried Blood Spot Sample Collection

    Article • Antimicrobial Agents and Chemotherapy, January 2016, ASM Journals

    Dr Thomas Petrus Catharina Dorlo

  4. Population pharmacokinetics of levamisole in children with steroid-sensitive nephrotic syndrome

    Article • British Journal of Clinical Pharmacology, June 2015, Wiley

    Dr Thomas Petrus Catharina Dorlo, Mrs Rosan kreeftmeijer-vegter

  5. Systematic Review of Biomarkers To Monitor Therapeutic Response in Leishmaniasis

    Article • Antimicrobial Agents and Chemotherapy, November 2014, ASM Journals

    Dr Thomas Petrus Catharina Dorlo

  6. Different liposomal amphotericin B formulations for visceral leishmaniasis

    Article • The Lancet Global Health, August 2014, Elsevier

    Dr Thomas Petrus Catharina Dorlo

  7. Failure of Miltefosine Treatment for Visceral Leishmaniasis in Children and Men in South-East Asia

    Article • PLoS ONE, June 2014, PLOS

    Dr Thomas Petrus Catharina Dorlo

  8. LeishMan Recommendations for Treatment of Cutaneous and Mucosal Leishmaniasis in Travelers, 2014

    Article • Journal of Travel Medicine, March 2014, Oxford University Press (OUP)

    Dr Thomas Petrus Catharina Dorlo, Professor Pierre A Buffet

  9. Failure of Miltefosine in Visceral Leishmaniasis Is Associated With Low Drug Exposure

    Article • The Journal of Infectious Diseases, January 2014, Oxford University Press (OUP)

    Dr Thomas Petrus Catharina Dorlo

  10. Safety and Efficacy of Single Dose versus Multiple Doses of AmBisome® for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial

    Article • PLoS Neglected Tropical Diseases, January 2014, PLOS

    Dr Thomas Petrus Catharina Dorlo

  11. Reply to Arya and Agarwal

    Article • Clinical Infectious Diseases, June 2013, Oxford University Press (OUP)

    Dr Thomas Petrus Catharina Dorlo

  12. Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance

    Article • Clinical Infectious Diseases, February 2013, Oxford University Press (OUP)

    Dr Thomas Petrus Catharina Dorlo

  13. Please, let not Western quackery replace traditional medicine in Africa

    Article • Tropical Medicine & International Health, December 2012, Wiley

    Dr Thomas Petrus Catharina Dorlo

  14. Adherence to miltefosine treatment for visceral leishmaniasis under routine conditions in Nepal

    Article • Tropical Medicine & International Health, November 2012, Wiley

    Dr Thomas Petrus Catharina Dorlo

  15. Commentary: Substandard medicines are the priority for neglected tropical diseases

    Article • BMJ, November 2012, BMJ

    Dr Thomas Petrus Catharina Dorlo

  16. Universal access to quality medicines: prioritisation of a-priori solutions

    Article • The Lancet Infectious Diseases, November 2012, Elsevier

    Dr Thomas Petrus Catharina Dorlo

  17. Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis

    Article • Journal of Antimicrobial Chemotherapy, July 2012, Oxford University Press (OUP)

    Dr Thomas Petrus Catharina Dorlo

  18. A Poor-Quality Generic Drug for the Treatment of Visceral Leishmaniasis: A Case Report and Appeal

    Article • PLoS Neglected Tropical Diseases, May 2012, PLOS

    Dr Thomas Petrus Catharina Dorlo

  19. Optimal Dosing of Miltefosine in Children and Adults with Visceral Leishmaniasis

    Article • Antimicrobial Agents and Chemotherapy, May 2012, ASM Journals

    Dr Thomas Petrus Catharina Dorlo

  20. Translational pharmacokinetic modelling and simulation for the assessment of duration of contraceptive use after treatment with miltefosine

    Article • Journal of Antimicrobial Chemotherapy, May 2012, Oxford University Press (OUP)

    Dr Thomas Petrus Catharina Dorlo

  21. Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults

    Article • Journal of Antimicrobial Chemotherapy, February 2012, Oxford University Press (OUP)

    Dr Thomas Petrus Catharina Dorlo

  22. Characterization and identification of suspected counterfeit miltefosine capsules

    Article • The Analyst, January 2012, Royal Society of Chemistry

    Dr Thomas Petrus Catharina Dorlo

  23. Dynamics of Parasite Clearance in Cutaneous Leishmaniasis Patients Treated with Miltefosine

    Article • PLoS Neglected Tropical Diseases, December 2011, PLOS

    Dr Thomas Petrus Catharina Dorlo

  24. Safety and Efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial

    Article • Trials, June 2011, Springer Science + Business Media

    Dr Thomas Petrus Catharina Dorlo

  25. Severe encephalopathy and polyneuropathy induced by dichloroacetate

    Article • Journal of Neurology, July 2010, Springer Science + Business Media

    Dr Thomas Petrus Catharina Dorlo

  26. Comment on: Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, January 2010, Oxford University Press (OUP)

    Dr Thomas Petrus Catharina Dorlo

  27. Pharmacokinetics of Miltefosine in Old World Cutaneous Leishmaniasis Patients

    Article • Antimicrobial Agents and Chemotherapy, June 2008, ASM Journals

    Dr Thomas Petrus Catharina Dorlo

  28. Pentamidine Dosage: A Base/Salt Confusion

    Article • PLoS Neglected Tropical Diseases, May 2008, PLOS

    Dr Thomas Petrus Catharina Dorlo

  29. Development and validation of a quantitative assay for the measurement of miltefosine in human plasma by liquid chromatography–tandem mass spectrometry

    Article • Journal of Chromatography B, April 2008, Elsevier

    Dr Thomas Petrus Catharina Dorlo